ArticleMolecular biotechnology2026

An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine Antigen.

Sanaz Majidi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.